People taking GLP-1 weight loss drugs like Ozempic started moving less

People with obesity who lost weight while taking popular medications such as Ozempic, Wegovy, Mounjaro, and Zepbound became significantly less physically active, according to research presented Saturday at ENDO 2026, the Endocrine Society’s annual meeting in Chicago, Illinois.

Click here to view the original article.